Who is Lantheus?

Lantheus Medical Imaging is a worldwide leader in medical imaging, with headquarters in North Billerica, Massachusetts, and nearly 700 employees worldwide with offices in Puerto Rico, Canada, and Australia. For more than half a century, the company has provided important products—including Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension and TechneLite® (Technetium Tc99m Generator) —that illuminate the heart and other organs. Lantheus Medical Imaging will build on the solid foundation created by those products as we seek out new ways of “bringing light” to the diagnosis and management of disease.

What’s In a Name?

We are proud of our company’s new name and its meaning.  Leading the word Lantheus is the root word “lantern,” which connotes illumination and discovery. The “-eus” suffix is powerful, communicating strength and leadership with its echo of the names of mythological gods. And the word “us” is incorporated in that suffix—appropriate because our success is inextricably linked with that of our customers and each other, as well as the care of the patients we ultimately serve.